TFF Pharmaceuticals Inc. (TFFP) Tops Q2 EPS by 5c

TFF Pharmaceuticals Inc. (NASDAQ: TFFP) reported Q2 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $333.35 thousand versus the consensus estimate of $66.67 thousand.

For earnings history and earnings-related data on TFF Pharmaceuticals Inc. (TFFP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c